Koyfin Home > Directory > Health Care > Aquestive Therapeutics Inc > Cash from Financing Activities

Aquestive Therapeutics Inc Cash from Financing Activities Chart (AQST)

Aquestive Therapeutics Inc annual/quarterly Cash from Financing Activities from 2006 to 2018.
  • Aquestive Therapeutics Inc Cash from Financing Activities for the quarter ending September 09, 2018 was $65m a 100.87% increase of 66m year over year
  • Aquestive Therapeutics Inc Cash from Financing Activities for the last 12 months ending September 09, 2018 was $58m a 92.33% increase of 53m year over year
  • Aquestive Therapeutics Inc Annual Cash from Financing Activities for 2017 was $4m a -28.89% decrease of -1m from 2016
  • Aquestive Therapeutics Inc Annual Cash from Financing Activities for 2016 was $6m a -366.50% decrease of -21m from 2015
  • Aquestive Therapeutics Inc Annual Cash from Financing Activities for 2006 was $27m a 61.48% increase of 16m from 2005
Other Cash Flow Metrics:
  • Aquestive Therapeutics Inc Cash Flow from Operations for the quarter ending September 09, 2018 was $-11m a 35.43% decrease of -4m year over year
  • Aquestive Therapeutics Inc Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-6m a 59.44% decrease of -4m year over year
  • Aquestive Therapeutics Inc Total Revenue for the quarter ending December 12, 2018 was $17m a -39.15% decrease of -7m year over year
View Chart On Koyfin

Quarterly AQST Cash from Financing Activities Data

09/2018$65m
06/2018$-6m
03/2018$-1m
12/2017$-1m
09/2017$0m
06/2017$0m
03/2017$5m
06/2007$0m
03/2007$0m
12/2006$9m

Annual AQST Cash from Financing Activities Data

2017$4m
2016$6m
2006$27m
2005$10m
2004$5m